We also observed a nonsignificant trend in this cohort towards a lower firmicutes to bacteroidetes ratio following MGN1703 dosing.
← all excerpts
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.
1
—
—
We also observed a nonsignificant trend in this cohort towards a lower firmicutes to bacteroidetes ratio following MGN1703 dosing.